Source: BioPortfolio

NovImmune: Sobi acquire Novimmune in deal worth more than £400 million httpbit.ly31xbFeS pharma biotech immunologypic.twitter.commUGnxDDLJC

Sobi acquire Novimmune in deal worth more than £400 million httpbit.ly31xbFeS pharma biotech immunology pic.twitter.commUGnxDDLJC

Read full article »
NovImmune's Competitors | NovImmune's News | NovImmune's Financials
Stay up-to-date with the latest news on NovImmune
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Erik Trock Jansen's photo - CEO of NovImmune

CEO

Erik Trock Jansen

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on NovImmune